Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
Function Oncology Launches to Transform the Future of Targeted Cancer Treatment with CRISPR-powered Personalized Functional Genomics Platform streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Reports record revenue, expects revenue of $2,265-2,315 million and positive adjusted EBITDA for full year 2023 Fourth quarter and 2022 highlights Total fourth.
The Baltimore company showed the path for a company spun out of Johns Hopkins research to grow from a base in the city. Now it will join a prominent, global name in life sciences.